After last week’s losses prompted a flurry of profit-taking after a long period of gains, today it was back to picking up bargains, that combined with optimism over this Thursday’s upcoming inflation report. After a short period of caution, “enough people might be looking to put some money to work.” It was a shot straight up on all three indexes, the Dow up an impressive 407 points, tech being a little more subdued with the Fed still predicting more rate hikes though the New York prez said a break could be coming as soon as early 2024. The Nasdaq has snapped a four session losing streak, the S&P too. Q2 S&P is humming along with 79% of 422 companies beating estimates. Volume was below average at 9.9 billion.
Wall St closes up, regains ground as US
inflation report nears
By David
French
Mon August 7, 2023 4:43
PM
DJ: 35,065.62 -150.27 NAS: 13,909.24 -50.48 S&P: 4,478.03 -23.86 8/4
DJ: 35,473.13 +407.50 NAS: 13,994.40 +85.16 S&P: 4,518.44
+40.41 8/7
Aug 7 (Reuters) - U.S.
stocks finished higher on Monday, regaining some of the ground lost last week,
as investors added positions ahead of Thursday's highly awaited U.S. inflation
report. The main stock indexes ended
last week lower as investors took profits after months of gains due to worries
over economic data, mixed earnings and rising Treasury yields. U.S. stocks have sharply rallied in 2023,
with the benchmark S&P 500 (.SPX) rising 17.7% this year, fueled by
optimism around artificial intelligence and hopes of a soft landing for the
world's largest economy.
"I think you've got enough people that might be looking to put some money to
work, because they've really missed a lot of this rally, so that will
limit any downside (from bouts of profit-taking)," said Jack Janasiewicz,
lead portfolio strategist at Natixis Investment Managers. He noted to expect some sideways trading in
the near term, as profit-taking by investors who rode the rally balances out
with those entering on any weakness. While
August trading is seasonally slower with summer vacations, set events and data
releases can still offer investors new food for thought.
On Thursday, the latest
U.S. consumer price report is expected to offer clues about the Federal Reserve's monetary policy path, after Friday's employment report re-ignited fears
that the central bank could keep rates higher for longer. New York Fed President John Williams, a voting member this year, said he
expects interest rates
could begin to slide in early 2024, as per a report, while Governor Michelle
Bowman said additional
interest rate hikes will likely be needed to lower inflation to the 2%
target.
The Dow Jones Industrial Average (.DJI) rose 407.51 points, or 1.16%, to 35,473.13 - its largest one-day gain since June 15. Meanwhile, the S&P 500 (.SPX) gained 40.41 points, or 0.90%, at 4,518.44, and the Nasdaq Composite (.IXIC) added 85.16 points, or 0.61%, at 13,994.40. The tech-heavy Nasdaq snapped a four-session losing streak, matching its longest negative run this year. It overcame weakness in Tesla (TSLA.O), which dropped 0.9% after the electric vehicle giant named Vaibhav Taneja to replace Zachary Kirkhorn as its finance chief. The Nasdaq also finished lower for four straight days at the start of May. Before that, the longest losing streak was a six-session drop in October. The S&P 500 also snapped a four-session losing run. It has had two other such stretches in 2023: at the start of May and in February. It had a five-session skid in December. Most of the S&P's major indexes rose, led by gains of 1.9% in communication services (.SPLRCL) and 1.4% in financials (.SPSY).
Overall, second-quarter earnings have been better than expected so far, with 79.1% of the 422 S&P 500 companies that have reported as of Friday beating analysts' estimates, Refinitiv data shows.
Berkshire Hathaway(BRKa.N) rose 3.4% to a record high, after
the conglomerate run by billionaire investor Warren Buffett reported at the
weekend that quarterly operating profit topped $10 billion for the first time. However, Tyson Foods (TSN.N) slid 3.8% after the meat packer
disappointed Wall Street expectations for third-quarter revenue. Vaccine makers BioNTech SE and Moderna Inc (MRNA.O) slumped 7.5% and 6.5%, respectively. The
former said it was cutting its drug development budget after quarterly revenue
was hurt by a plunge in pandemic-related demand. The latter was hit by
investment bank Leerink cutting its price target for the company. Sage Therapeutics (SAGE.O) suffered its biggest one-day
decline since December 2019, dropping 53.6%, after the U.S. drug regulator
declined to approve a first-of-its-kind postpartum depression (PPD) pill. Its
partner on the drug, Biogen (BIIB.O), recovered to trade 0.9% higher.
Volume on U.S. exchanges was 9.92 billion shares, compared with the 10.86 billion average for the full session over the last 20 trading days.
The S&P 500 posted 19 new 52-week highs and eight new lows;
the Nasdaq Composite recorded 71 new highs and 169 new lows.
No comments:
Post a Comment